MRD Response in Relapsed/Refractory FL After Obinutuzumab Plus Bendamustine or Bendamustine Alone
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Leukemia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
MRD Response in Relapsed/Refractory FL After Obinutuzumab Plus Bendamustine or Bendamustine Alone in the GADOLIN Trial
Leukemia 2019 Aug 28;[EPub Ahead of Print], C Pott, LH Sehn, D Belada, J Gribben, E Hoster, B Kahl, B Kehden, E Nicolas-Virelizier, N Spielewoy, G Fingerle-Rowson, C Harbron, K Mundt, E Wassner-Fritsch, BD ChesonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.